Brands like Lemme, Arrae and Perelel are betting big on ingredients like creatine, collagen and protein, that support muscle ...
8h
Verywell Health on MSNContrave vs. Wegovy: How Do They Compare for Weight Loss?Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...
The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...
The Good Bug’s formulation, priced at Rs 2,000 per month, is based on microbiome research. A randomised, double-blinded, ...
GUBamy was well tolerated with adverse events being predominantly GI related, mild and consistent with data from the SAD study.Doses of 1 mg and 2 mg GUBamy ...
Talat Imran; Chief Executive Officer, Director; Rani Therapeutics Holdings Inc Svai Sanford; Chief Financial Officer; Rani Therapeutics Holdings Inc Welcome to the Rani fourth-quarter and full-year ...
Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported ...
AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.
2h
News-Medical.Net on MSNRare sugars curb appetite and mimic diabetes drugs in miceBy Hugo Francisco de Souza Can rare sugars help control appetite and fight obesity? New research in mice suggests sweet solutions may lie in your gut hormones. Study: Abilities of Rare Sugar Members ...
Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.
The fitness influencer Kenny Boulet, who asks gymgoers if they’re “natty or not,” wants people to be more honest about their steroid use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results